TRANXENOGEN

TranXenoGen, Inc is a publicly traded biotechnology company listed on the Alternative Investment Market of the London Stock Exchange (TXN.L). The Company is focused on developing new methods for manufacturing therapeutic proteins and a portfolio of products. Its product pipeline includes Anti-Neoplastic Urinary Protein ("ANUP") for the treatment of several types of cancer, Insulin and Human Serum Albumin ("HSA"). The Company believes that its technology platform will have multiple applications including the generation of transgenic chickens for the manufacture of high volume therapeutic proteins, animal models for the study of disease, and high throughput production of antibodies from genomic derived targets for product identification. TranXenoGen is developing its technology platform for the production of generic biologicals (e.g., Insulin and HSA), contract manufacturing of third party products and potential applications in the areas of biodefense and vaccine development. In..

Also known as: TRANXENOGEN, INC., TRANXENOGEN.COM

Primary location: Northboro United States